281 related articles for article (PubMed ID: 17692787)
1. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy.
Raichlin ER; McConnell JP; Lerman A; Kremers WK; Edwards BS; Kushwaha SS; Clavell AL; Rodeheffer RJ; Frantz RP
J Heart Lung Transplant; 2007 Aug; 26(8):826-33. PubMed ID: 17692787
[TBL] [Abstract][Full Text] [Related]
2. Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation.
Biadi O; Potena L; Fearon WF; Luikart HI; Yeung A; Ferrara R; Hunt SA; Mocarski ES; Valantine HA
J Heart Lung Transplant; 2007 Apr; 26(4):324-30. PubMed ID: 17403472
[TBL] [Abstract][Full Text] [Related]
3. Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipients.
Singh N; Jacobs F; Rader DJ; Vanhaecke J; Van Cleemput J; De Geest B
J Heart Lung Transplant; 2014 May; 33(5):499-506. PubMed ID: 24630408
[TBL] [Abstract][Full Text] [Related]
4. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients.
Raichlin E; McConnell JP; Bae JH; Kremers WK; Lerman A; Frantz RP
Transplantation; 2008 Apr; 85(7):963-8. PubMed ID: 18408575
[TBL] [Abstract][Full Text] [Related]
6. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
[TBL] [Abstract][Full Text] [Related]
7. Is Shift Work Associated with Lipid Disturbances and Increased Insulin Resistance?
Alefishat E; Abu Farha R
Metab Syndr Relat Disord; 2015 Nov; 13(9):400-5. PubMed ID: 26357004
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Dulbecco CA; Reaven GM
Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):366-373. PubMed ID: 28254109
[TBL] [Abstract][Full Text] [Related]
9. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state.
Tamakoshi K; Yatsuya H; Kondo T; Hori Y; Ishikawa M; Zhang H; Murata C; Otsuka R; Zhu S; Toyoshima H
Int J Obes Relat Metab Disord; 2003 Apr; 27(4):443-9. PubMed ID: 12664077
[TBL] [Abstract][Full Text] [Related]
11. Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children.
Agirbasli M; Tanrikulu A; Acar Sevim B; Azizy M; Bekiroglu N
J Clin Lipidol; 2015; 9(2):195-200. PubMed ID: 25911075
[TBL] [Abstract][Full Text] [Related]
12. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
[TBL] [Abstract][Full Text] [Related]
13. Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients.
Labarrere CA; Woods JR; Hardin JW; Jaeger BR; Zembala M; Deng MC; Kassab GS
PLoS One; 2014; 9(12):e113260. PubMed ID: 25490200
[TBL] [Abstract][Full Text] [Related]
14. TRIGLYCERIDE/HIGH-DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION RATIO IDENTIFIES ACCENTUATED CARDIOMETABOLIC RISK.
Armato J; Reaven G; Ruby R
Endocr Pract; 2015 May; 21(5):495-500. PubMed ID: 25667373
[TBL] [Abstract][Full Text] [Related]
15. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.
Sharples LD; Jackson CH; Parameshwar J; Wallwork J; Large SR
Transplantation; 2003 Aug; 76(4):679-82. PubMed ID: 12973108
[TBL] [Abstract][Full Text] [Related]
17. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.
Vega GL; Barlow CE; Grundy SM; Leonard D; DeFina LF
J Investig Med; 2014 Feb; 62(2):345-9. PubMed ID: 24402298
[TBL] [Abstract][Full Text] [Related]
18. Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients.
Marotta T; Russo BF; Ferrara LA
Obesity (Silver Spring); 2010 Aug; 18(8):1608-13. PubMed ID: 20019684
[TBL] [Abstract][Full Text] [Related]
19. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.
Kuller LH; Grandits G; Cohen JD; Neaton JD; Prineas R;
Atherosclerosis; 2007 Nov; 195(1):122-8. PubMed ID: 17011566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
